Neurocrine Biosciences, Inc.NBIXNASDAQ
LOADING
|||
Total earnings after all expenses, taxes, and interest
| Period | Value | Change |
|---|---|---|
| 2024 | $341.30M | +36.7% |
| 2023 | $249.70M | +61.6% |
| 2022 | $154.50M | +72.4% |
| 2021 | $89.60M | -78.0% |
| 2020 | $407.30M | +1000.8% |
| 2019 | $37.00M | +75.3% |
| 2018 | $21.11M | +114.8% |
| 2017 | $-142.54M | -1.0% |
| 2016 | $-141.09M | -58.7% |
| 2015 | $-88.93M | - |